GHK-Cu side effects: what the studies found
Real adverse event rates, clinical trial discontinuation numbers, and documented safety warnings from peer-reviewed literature.
This page has not yet been reviewed by a credentialed medical professional. It is educational and is not medical advice.
Safety summary: GHK-Cu
- Evidence level Animal studies only
- FDA approvedYes
- Trial discontinuationClinical discontinuation for topical formulations is negligible
- WADA sport statusCheck current list
In short: Topical use is generally considered low risk; skin irritation is the usual concern. For injectable GHK-Cu there is no human safety data. Copper is an essential mineral but is toxic in excess, and unregulated injectables may vary in dose and purity.
Not approved as an injectable drug by the FDA or any major health authority.
Most common side effects
Reported symptoms in clinical trials and published pharmacology literature:
| Symptom | Reported rate | Clinical context & notes |
|---|---|---|
| Mild skin irritation (topical) | < 2% | Occasional mild erythema, dryness, or contact dermatitis when used in concentrated cosmetic serums. |
| Injection site pain (subcutaneous) | Frequent in user reports | Subcutaneous injections of copper tripeptide often cause localized stinging, nodules, or bruising. |
Serious risks and warnings
Potential adverse reactions and biological risks identified in research:
- Systemic copper accumulation (injectable): Unlike topical creams, subcutaneous injection delivers free copper directly into systemic circulation. Chronic excessive copper intake can cause hepatotoxicity and oxidative tissue damage.
- Unregulated injectable formulation risk: GHK-Cu is approved strictly as a cosmetic topical ingredient. Injectable forms sold online are unregulated and unapproved.
Contraindications
This compound should not be used in individuals with:
- Wilson disease or copper metabolism disorders
- Known allergy to copper or peptide compounds
- Subcutaneous injection without medical authorization
Common questions about GHK-Cu safety
Is GHK-Cu safe to inject?
No clinical trials have tested the safety of injecting GHK-Cu in humans. While topical cosmetic creams have a strong safety record, injecting copper tripeptide risks systemic copper toxicity, localized tissue necrosis, and contamination from unsterile vials.
Can GHK-Cu irritate sensitive skin?
Topical GHK-Cu is generally well tolerated, but high concentrations or combining it with strong acids (like vitamin C or AHAs) can cause skin stinging, redness, or peeling.
Does GHK-Cu cause copper toxicity?
Topical cosmetic use does not cause systemic copper toxicity because systemic absorption through intact skin is very low. However, injecting high doses bypassing the skin barrier carries significant theoretical risk.